Recent news from 2020 highlights PreAxia's reliance on temporary regulatory filing relief, clarifying its regulatory compliance status.

• PreAxia Health Care Payment Systems Inc. clarified its reliance on temporary regulatory filing relief in a public statement in September 2020 [N1].
• In August 2020, the company announced its intention to rely on temporary regulatory filing relief [N2].

PreAxia's integrated approach combining health spending account management with AI-driven personal financial tools addresses emerging consumer and employer needs in healthcare financing and personal finance. The focus on Generation Z with innovative features like a High-Interest Super Account and Smart Debit Card could attract a new demographic underserved by traditional financial services. The company's cloud-based platform and planned strategic alliances may enable scalable growth in Canada and the US markets. Successful capital raises and execution of product development could position PreAxia as a unique fintech player bridging healthcare and personal finance sectors.

PreAxia faces significant risks due to its early-stage status, lack of revenue, and substantial working capital deficits. The company depends heavily on raising additional capital to fund operations, with no assurance of obtaining financing on favorable terms. Competition from established HSA providers and fintech companies with more mature products and customer bases may limit market penetration. The absence of patents or trademarks reduces barriers to entry. Execution risks include product development delays, regulatory challenges, and difficulty in attracting and retaining customers and strategic partners. Failure to secure sufficient funding could force scaling down or cessation of operations.

PreAxia's moat is limited given its early-stage development status and lack of registered patents or trademarks. The company aims to differentiate through a comprehensive digital platform integrating health spending account management with AI-powered personal financial management tools targeting Generation Z. Its cloud-based platform and dual headquarters in Canada and the US provide geographic and regulatory positioning. However, competition from established HSA providers and fintech companies with existing market presence and brand recognition presents significant challenges. The company's ability to establish strategic alliances and gain market traction will be critical to building competitive advantages.

• Capital and Liquidity Risk: The company has significant working capital deficits and limited cash reserves, relying on additional capital raises to fund operations. There is no assurance that financing will be available on commercially reasonable terms, posing a risk to continued operations.
• Early-Stage Development and Execution Risk: Products are in the development stage with no current revenue. Execution risks include delays in product development, market acceptance, and building a customer base.
• Competitive Risk: PreAxia faces competition from established Canadian HSA providers and fintech companies offering similar or alternative financial management solutions, which may limit market share.
• Regulatory and Compliance Risk: Operating in the healthcare payment and financial services sectors involves navigating complex regulatory environments in Canada and the US, which may impact operations and product offerings.
• Dependence on Key Personnel and Partners: The company currently has limited staff and relies on consultants and contractors. Success depends on hiring and retaining qualified personnel and establishing strategic alliances.
• Cybersecurity Risk: The company is in the process of developing procedures to manage cybersecurity risks but currently does not maintain customer lists or sensitive data, which may expose it to future cybersecurity threats.

• PreAxia Health Care Payment Systems Inc. was incorporated in Nevada in 2000 and operates primarily through its wholly owned subsidiary PreAxia Health Care Payment Limited, incorporated in Alberta, Canada in 2015 [S1][S2].
• The company created two subsidiaries in 2025: Zane Inc. CA (Alberta) and Zane Inc US (Nevada), focused on developing and marketing personal financial management products and healthcare payment processing services [S1][S2].
• PreAxia targets the emerging health payment market, specifically health spending accounts (HSAs), aiming initially at the Canadian market with plans to expand to the US and internationally [S1][S2].
• The company’s platform is designed to manage HSAs digitally, eliminating paper processes and providing account management, reconciliation, financial settlement, and reporting services [S1].
• Zane’s product philosophy centers on an AI-powered personal financial management super-app for Generation Z, featuring a High-Interest Super Account, Smart Debit Card with spending limits, and MoneyNet distributed financial network [S1][S2].
• PreAxia and Zane operate on cloud computing platforms with technology development in Calgary and regulatory operations in major US and Canadian financial centers [S1].
• The company’s marketing strategy focuses on small to medium-sized businesses, brokers, and financial advisors, aiming to establish key customer references and strategic alliances with employers, insurance companies, and governments [S1].
• PreAxia faces competition from established Canadian HSA providers such as Benecaid, Olympia Benefits, QuickCard, and mobile money management services like Zelle [S1].
• As of November 30, 2025, the company had cash and equivalents of $13,846 and a working capital deficit of $754,919, showing improvement from a deficit of $2,341,169 as of May 31, 2025 [S2].
• The company reported zero revenue for the six months ended November 30, 2025, and a net loss of $111,820 for the same period [S2].
• Operating expenses increased significantly in 2025 compared to 2024, driven by consulting, management, professional fees, and research and development costs related to software development and product launch efforts [S2].
• The company’s ability to continue operations depends on raising additional capital, with no assurance of obtaining financing on commercially reasonable terms [S1][S2].
• PreAxia has no patents or trademarks currently registered [S1].
• The company has one full-time consultant (President) and plans to hire additional staff in administration, business development, operations, sales, marketing, and research and development [S1].
• The company has clarified reliance on temporary regulatory filing relief in public news releases from 2020 [N1][N2].